Healthcare Innovation April 25, 2023
By Mark Hagland

Senators Susan Collins and Jeanne Shaheen have introduced a bipartisan bill aimed at curbing the cost of insulin in the U.S., into the Senate

Bipartisan legislation to control the cost of insulin to healthcare consumers and patients has been introduced into the U.S. Senate. On April 21, Senators Susan Collins (R-Maine) and Jeanne Shaheen (D-New Hampshire), introduced their INSULIN Act of 2023.

As a press release posted to Senator Collins’s Senate office website stated, “U.S. Senators Susan Collins (R-ME) and Jeanne Shaheen (D-NH), co-chairs of the Senate Diabetes Caucus, introduced their bipartisan legislation, the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act of 2023, on Thursday, which would comprehensively address the skyrocketing costs of insulin, removing barriers...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, Regulations
Where Medicaid cuts stand
Will Congress’s new AI plan survive Trump?
Black Book Finds Tariff Pressures Driving Reshoring of U.S. Healthcare Manufacturing
Trump administration announces new tariff plan
ACA enrollment increase driven by growth in states won by Trump: KFF

Share This Article